Eicosanoids from biopsy of normal and polypous nasal mucosa

Rhinology

Volumn 34, Issue 3, 1996, Pages 166-170

  Baenkler, H W ^a,b   Schafer D ^a   Hosemann, W ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Medical Clinic III   (Germany)

Author keywords

Biopsy; Nasal polyps; Peptido leukotrienes; Prostaglandin E2; Thromboxane B2

Indexed keywords

PEPTIDOLEUKOTRIENE; PROSTAGLANDIN E2; THROMBOXANE B2;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; NOSE POLYP;

BIOPSY; CASE-CONTROL STUDIES; DINOPROSTONE; HUMANS; IMMUNOENZYME TECHNIQUES; LEUKOTRIENES; NASAL MUCOSA; NASAL POLYPS; RADIOIMMUNOASSAY; THROMBOXANE B2;

EID: 0029901768     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Baenkler HW, Schaubschläger W, Behnsen H (1983) Antigen induced histamine release from mucosa in nasal polyposis. Clin Otolaryngol 8: 227-230.
2. Baenkler HW, Dechant F, Hosemann W (1987) In vitro histamine release from nasal mucosa upon bacterial antigens. Rhinology 25: 17-22.
3. Bradford MM (1976) A rapid and sensitive method for the quantisation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
4. Brandtzaeg P (1984) Immune functions of human nasal mucosa and tonsils in health and disease. In: J Bienenstock (Ed.) Immunology of Lung and Upper Respiratory Tract. McGraw-Hill, New York, pp. 29-95.
5. Brune K, Reinke M, Lanz R, Peskar BA (1985) Monoclonal antibodies against E- and F-type prostaglandins. FEBS 2644/189: 46-50.
6. Bunnag C, Pacharee P, Vipulakom P, Siriyananda C (1983) A study of allergic factor in nasal polyp patients. Ann Allergy 50: 126-132.
7. Calenoff E, Guilford T, Green I, Engelhard CS (1983) Bacteria-specific IgE in patients with nasal polyps. Arch Otolaryngol 109: 372-375.
8. Carter GW, Young PR, Albert DH, Bouska JB, Dyer RD, Bell RL, Summers JB, Brooks DW, Gunn BP, Rubin P, Kesterson J (1989) In: U Zor, Z Naor, A Danon (Eds.) Leukotrienes and Prostanoids in Health and Disease, Volume 3. Karger, Basel, pp. 50-55.
9. Evans JF, Léveillé C, Mancini JA, Prasit P, Thérien M, Zamboni R, Gauthier JY, Fortin R, Charleson P, MacIntyre DE, Luell S, Bach TJ, Meurer R, Guay J, Vickers PJ, Rouzer CA, Gillard JW, Miller DL (1991) 5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors. Mol Pharmacol 40: 22-27.
10. Flower JR (1988) Lipocortin and the mechanism of action of the glucocorticoids. Br J Pharmacol 94: 987-1015.
11. Frenkiel S, Chagnon F, Small P, Rochon L, Cohen C, Black M (1985) The immunological basis of nasal polyp formation. J Otolaryngol 14: 89-91.
12. 4 release from activated neutrophils. Proc Natl Acad Sci 80: 4349-4353.
13. Hedqvist P, Raud J, Palmertz U, Kumlin M, Dahlen SE (1990) Eicosanoids as mediators and modulators of inflammation. Adv Prostglandin Thromboxane and Leukotriene Res 21: 537-543.
14. Jung T, Juhn S, Hwang D, Stewart R (1987) Prostaglandins, leukotrienes and other arachidonic acid metabolites in nasal polyps and nasal mucosa. Laryngoscope 97: 184-189.
15. Larocca LM, Maggiano N, Capelli A, Bevilacqua P, Ruscito P, Maurizi M, Bellioni P (1989) Immunopathology of nasal polyps: An immunohistochemical approach. Ann Allergy 63: 508-512.
16. 2. Immunology 145: 2616-2625.
17. McConcey DJ, Orreniis S, Jondal M (1990) Cellular signalling in programmed cell death (apoptosis). Immunology Today 11: 120-121.
18. Ohashi Y, Nakai Y, Nakata J, Kihara S, Ikeoka H (1986) Nasal allergy and nasal polyps with special reference to the mucosal IgE antibodies. ORL 48: 233-237.
19. Pipkorn U, Karlsson G (1988) Methods for obtaining specimens from the nasal mucosa for morphological and biochemical analysis. Eur Resp J 1: 856-862.
20. 2 using a monoclonal antibody. Prostaglandins 37: 577-586.
21. 4. Biochim Biophys Acta 1081: 274-278.
22. Romeis B (1989) Mikroskopische Techniken. Urban and Schwarzenberg Verlag, München, pp. 474, 501, 213.
23. Schramm VL, Effron MZ (1988) Nasal polyps in children. Laryngoscope 90: 1488-1495.
24. Settipane GA (1987) Nasal polyps: Epidemiology, pathology, immunology, and treatment. Am J Rhinology 13: 119-126.
25. Slivka A, LoBuglio AF, Weiss SF (1980) A potential role for hypochlorous acid in granulocyte-mediated tumour cell cytotoxicity. Blood 55: 347-350.
26. Smith DM, Gerrard JM, Juhn SK, White JG (1981) Arachidonic acid metabolism in nasal polyps and allergic inflammation. Minn Med 64: 605-610.
27. Stoop AE (1992) Immunobiological Aspects of Nasal Polyps. PhD-Thesis, University of Utrecht, The Netherlands.
28. 4. Immunology 80: 7626-7630.
29. Whorton AR (1983) Measurement of prostaglandin production by isolated tissue and cells in culture. Methods Enzymol 141: 341-350.
30. Wollenberger A, Ristau O, Schoffa G (1960) Eine einfache Technik der extrem schnellen Abkühlung größerer Gewebestücke. Pflüglers Archiv 270: 399-412.
31. Zakar T, Eixeira FJ, Hirst JJ, Guo F, MacLeod EA, Olson DM (1994) Regulation of prostaglandin endoperoxide H-synthase by glucocorticoids and activators of protein kinase C in the human amnion. J Reprod Fertil 100: 43-50.